Mar 1, 2023 8:53 am EST Kane Biotech Announces Proposed Amendments to its Credit Facility and Changes to its Board of Directors
Feb 6, 2023 9:35 am EST Kane Biotech’s Coactiv+™ Technology Could Address a Pricey and Painful Problem: Lack of Healing in Chronic Wounds Due to Microbial Biofilm Formation
Jan 4, 2023 7:30 am EST Kane Biotech Announces First Distribution Agreement for its coactiv+™ Antimicrobial Hydrogel